|
Delayed
OTC Markets
22:46:37 25/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | - |
| Market Cap | 3.91M 2.76M 2.43M 2.3M 2.09M 264M 3.95M 27.6M 10.64M 135M 10.35M 10.12M 434M | P/E 2018 |
-4.94x | P/E 2019 | -0.37x |
|---|---|---|---|---|---|
| Enterprise Value | 9.13M 6.43M 5.68M 5.37M 4.87M 617M 9.22M 64.44M 24.84M 315M 24.16M 23.63M 1.01B | EV / Sales 2018 |
12.6x | EV / Sales 2019 | 2.48x |
| Free-Float |
100% | Yield 2018 * |
-
| Yield 2019 | - |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0 |
| Current year | 0 | | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0 |
| 5 years | 0 | | 0.29 |
| 10 years | 0 | | 16.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/2017 |
Andrew Alvis
DFI | Director of Finance/CFO | - | - |
| Corporate Officer/Principal | - | 30/08/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
BRD | Director/Board Member | - | 24/05/2017 |
| Director/Board Member | - | 30/08/2018 | |
| Director/Board Member | - | 21/11/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 128 | |
| -0.18% | -1.66% | -12.03% | -5.74% | 13.38B | |
| -0.13% | -1.52% | -31.87% | -57.47% | 4.77B | |
| -0.09% | -0.79% | -4.92% | -7.79% | 4.3B | |
| -0.86% | -3.66% | -5.00% | -35.98% | 3.77B | |
| -1.65% | -1.70% | -21.02% | -5.02% | 3.49B | |
| +0.85% | -0.36% | -0.04% | -9.03% | 3.39B | |
| -0.43% | -2.35% | -12.54% | -5.37% | 3.07B | |
| -0.07% | -2.10% | -20.81% | -19.31% | 2.24B | |
| -0.88% | -3.92% | -26.38% | -26.57% | 1.63B | |
| Average | -0.34% | -1.69% | -14.96% | -19.14% | 4B | |
| Weighted average by Cap. | -0.31% | -1.82% | -13.85% | -16.76% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 19.14M 13.48M 11.9M 11.26M 10.21M 1.29B 19.33M 135M 52.04M 661M 50.62M 49.52M 2.13B | 22.25M 15.67M 13.83M 13.09M 11.87M 1.5B 22.47M 157M 60.5M 768M 58.85M 57.56M 2.47B |
| Net income | -36.02M -25.37M -22.39M -21.19M -19.21M -2.43B -36.38M -254M -97.95M -1.24B -95.27M -93.2M -4B | -126M -88.69M -78.27M -74.05M -67.16M -8.51B -127M -888M -342M -4.35B -333M -326M -13.98B |
| Net Debt | -15.55M -10.95M -9.67M -9.15M -8.29M -1.05B -15.7M -110M -42.28M -537M -41.13M -40.23M -1.73B | 5.22M 3.68M 3.25M 3.07M 2.79M 353M 5.27M 36.85M 14.2M 180M 13.81M 13.51M 580M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/09/26 | $0.000001 | 0.00% | 2,000 |
- Stock Market
- Stocks
- ISOLF Stock
Select your edition
All financial news and data tailored to specific country editions
